BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35456704)

  • 21. Microfluidic assisted synthesis of PLGA drug delivery systems.
    Rezvantalab S; Keshavarz Moraveji M
    RSC Adv; 2019 Jan; 9(4):2055-2072. PubMed ID: 35516107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
    Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
    Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable poly (lactic acid) microspheres for drug delivery systems.
    Hyon SH
    Yonsei Med J; 2000 Dec; 41(6):720-34. PubMed ID: 11204823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple Microfluidic Approach to Fabricate Monodisperse Hollow Microparticles for Multidrug Delivery.
    Vasiliauskas R; Liu D; Cito S; Zhang H; Shahbazi MA; Sikanen T; Mazutis L; Santos HA
    ACS Appl Mater Interfaces; 2015 Jul; 7(27):14822-32. PubMed ID: 26098382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymeric Based Therapeutic Delivery Systems Prepared Using Electrohydrodynamic Processes.
    Rasekh M; Nazari K; Arshad MS; Kucuk I; Haj-Ahmad R; Hussain A; Morris MA; Abbas N; Chang MW; Li X; Ahmad Z
    Curr Pharm Des; 2016; 22(19):2873-85. PubMed ID: 26898734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bevacizumab-Controlled Delivery from Polymeric Microparticle Systems as Interesting Tools for Pathologic Angiogenesis Diseases.
    De Negri Atanasio G; Ferrari PF; Campardelli R; Firpo G; Perego P; Palombo D
    Polymers (Basel); 2022 Jun; 14(13):. PubMed ID: 35808639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs.
    Sun Z; Duan R; Xing D; Pang X; Li Z; Chen X
    Curr Cancer Drug Targets; 2017; 17(5):445-455. PubMed ID: 28067177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineered PLGA-PVP/VA based formulations to produce electro-drawn fast biodegradable microneedles for labile biomolecule delivery.
    Onesto V; Di Natale C; Profeta M; Netti PA; Vecchione R
    Prog Biomater; 2020 Dec; 9(4):203-217. PubMed ID: 33141337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review.
    Osi B; Khoder M; Al-Kinani AA; Alany RG
    Pharm Dev Technol; 2022 Mar; 27(3):341-356. PubMed ID: 35297285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Panorama of dissolving microneedles for transdermal drug delivery.
    Dalvi M; Kharat P; Thakor P; Bhavana V; Singh SB; Mehra NK
    Life Sci; 2021 Nov; 284():119877. PubMed ID: 34384832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
    Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
    Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
    Hu Y; Hollinger JO; Marra KG
    J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microfluidic Synthesis of Indomethacin-Loaded PLGA Microparticles Optimized by Machine Learning.
    Damiati SA; Damiati S
    Front Mol Biosci; 2021; 8():677547. PubMed ID: 34631792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-implanted tiny needles as alternative to traditional parenteral administrations for controlled transdermal drug delivery.
    Chen BZ; Yang Y; Wang BB; Ashfaq M; Guo XD
    Int J Pharm; 2019 Feb; 556():338-348. PubMed ID: 30553955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
    Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
    J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering microenvironment of biodegradable polyester systems for drug stability and release control.
    Khaliq NU; Chobisa D; Richard CA; Swinney MR; Yeo Y
    Ther Deliv; 2021 Jan; 12(1):37-54. PubMed ID: 33397135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of monomer order on the hydrolysis of biodegradable poly(lactic-co-glycolic acid) repeating sequence copolymers.
    Li J; Rothstein SN; Little SR; Edenborn HM; Meyer TY
    J Am Chem Soc; 2012 Oct; 134(39):16352-9. PubMed ID: 22950719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.